#term ID	term description	observed gene count	background gene count	strength	signal	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
WP4172	PI3K-Akt signaling pathway	11	336	0.81	0.68	0.0010	9606.ENSP00000241453,9606.ENSP00000252723,9606.ENSP00000267082,9606.ENSP00000274276,9606.ENSP00000288135,9606.ENSP00000297494,9606.ENSP00000297904,9606.ENSP00000302150,9606.ENSP00000311697,9606.ENSP00000386896,9606.ENSP00000397297	FLT3,EPO,ITGB7,OSMR,KIT,NOS3,VEGFD,PRL,FGF5,ITGA6,NTF3
WP5087	Malignant pleural mesothelioma	11	434	0.7	0.52	0.0054	9606.ENSP00000241453,9606.ENSP00000247668,9606.ENSP00000288135,9606.ENSP00000297904,9606.ENSP00000311697,9606.ENSP00000356954,9606.ENSP00000361405,9606.ENSP00000368710,9606.ENSP00000386896,9606.ENSP00000397297,9606.ENSP00000469413	FLT3,TRAF2,KIT,VEGFD,FGF5,CCN2,MMP9,RASSF2,ITGA6,NTF3,PAK4
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	9	301	0.77	0.52	0.0066	9606.ENSP00000252723,9606.ENSP00000267082,9606.ENSP00000274276,9606.ENSP00000288135,9606.ENSP00000297494,9606.ENSP00000297904,9606.ENSP00000302150,9606.ENSP00000386896,9606.ENSP00000477999	EPO,ITGB7,OSMR,KIT,NOS3,VEGFD,PRL,ITGA6,NOS1
WP4541	Hippo-Merlin signaling dysregulation	6	119	1.0	0.56	0.0076	9606.ENSP00000241453,9606.ENSP00000267082,9606.ENSP00000288135,9606.ENSP00000356954,9606.ENSP00000386896,9606.ENSP00000469413	FLT3,ITGB7,KIT,CCN2,ITGA6,PAK4
WP5095	Overview of proinflammatory and profibrotic mediators	6	126	0.98	0.54	0.0083	9606.ENSP00000231228,9606.ENSP00000252723,9606.ENSP00000280357,9606.ENSP00000286758,9606.ENSP00000354416,9606.ENSP00000361405	IL12B,EPO,IL18,CXCL13,CCL28,MMP9
WP5285	Immune infiltration in pancreatic cancer	4	38	1.32	0.59	0.0083	9606.ENSP00000231228,9606.ENSP00000297904,9606.ENSP00000354416,9606.ENSP00000361405	IL12B,VEGFD,CCL28,MMP9
WP1539	Angiogenesis	3	23	1.41	0.43	0.0324	9606.ENSP00000266085,9606.ENSP00000297494,9606.ENSP00000361405	TIMP3,NOS3,MMP9
